About this trial
Phase 1 objective: test the feasibility of using a 3Tesla MRI scanner instead of a 7Tesla MRI scanner to measure brainstem responses to LBNP in healthy participants.
Phase 2 primary objective: compare the brainstem responses to LBNP in patients with PD associated with OH to PD patients without OH using BOLD fMRI
Eligibility criteria
Qualifiers
Signed informed consent
Age ≥ 18 years and <75 years
Normal office blood pressure (<140/90 mmHg)
For women of childbearing potential: using or willing to use during the study a reliable contraception method compatible with MRI
Disqualifiers
Schellong test showing OH (drop of Systolic BP >20 mmHg or Diastolic BP >10 mmHg)
Pregnant or lactating women
Refusal to be informed of incidental findings
Any medication (acute or chronic prescription) except oral contraception
Trial design
Treatments tested in this trial
- Lower body negative pressure
Treatment groups
Sponsors and collaborators
Centre Hospitalier Universitaire Vaudois
Lead sponsor
Ecole Polytechnique Fédérale de Lausanne
Collaborator
University Hospital, Geneva
Collaborator